Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1)
Crossref DOI link: https://doi.org/10.1007/s00280-017-3365-y
Published Online: 2017-06-30
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yan, Xiaofei
Zhao, Jian
Zhang, Rui
Funding for this research was provided by:
the National Natural Science Foundation of China (81672427)
License valid from 2017-06-30